RAPID DIAGNOSTIC FOR CLOSTRIDIUM DIFFICILE TOXIN B

Information

  • Research Project
  • 3489367
  • ApplicationId
    3489367
  • Core Project Number
    R43AI030837
  • Full Project Number
    1R43AI030837-01
  • Serial Number
    30837
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/30/1991 - 32 years ago
  • Project End Date
    3/31/1992 - 32 years ago
  • Program Officer Name
  • Budget Start Date
    9/30/1991 - 32 years ago
  • Budget End Date
    3/31/1992 - 32 years ago
  • Fiscal Year
    1991
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/29/1991 - 33 years ago
Organizations

RAPID DIAGNOSTIC FOR CLOSTRIDIUM DIFFICILE TOXIN B

DESCRIPTION: (Adapted from the Applicant's Abstract) The long term objective of the research proposed here is to develop a rapid enzyme linked immunoassay for toxigenic C. difficile. C. difficile is the most frequent cause of antibiotic-associated diarrhea and colitis and the second most frequently identified cause of enteric disease in industrialized nations. Single treatment of patients with virtually any antibiotic can induce an overgrowth of intestinal microflora by C. difficile and cause disease. A very reliable diagnostic procedure which detects an exotoxin, Toxin B, already exists but requires 48 hours to perform and a sophisticated cell culture facility. Although effective therapy exists for C. difficile, it is usually withheld until the results of the cellular assay are known because a majority of samples assayed lack toxin. An alternative assay should require less time while preserving specificity for Toxin B. The investigators have developed a panel of murine MAbs specific for Toxin B, high titered Toxin B specific antisera, and purification methods for Toxin B. The research plan in this proposal will make use of conventional immunological methods to develop an antigen capture test using these reagents as they have previously done with adenovirus and rotavirus.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R43
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    ANTIGENICS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    LEXINGTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02421
  • Organization District
    UNITED STATES